BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22913212)

  • 21. Atorvastatin and simvastatin, but not pravastatin, up-regulate LPS-induced MMP-9 expression in macrophages by regulating phosphorylation of ERK and CREB.
    Lee DK; Park EJ; Kim EK; Jin J; Kim JS; Shin IJ; Kim BY; Lee H; Kim DE
    Cell Physiol Biochem; 2012; 30(3):499-511. PubMed ID: 22814256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of atorvastatin and simvastatin on atrial plateau currents.
    Vaquero M; Caballero R; Gómez R; Núñez L; Tamargo J; Delpón E
    J Mol Cell Cardiol; 2007 May; 42(5):931-45. PubMed ID: 17466325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences between statins on clinical endpoints: a population-based cohort study.
    Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC
    Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposite effects of pravastatin and atorvastatin on insulin sensitivity in the rat: role of vitamin D metabolites.
    Bełtowski J; Atanassova P; Chaldakov GN; Jamroz-Wiśniewska A; Kula W; Rusek M
    Atherosclerosis; 2011 Dec; 219(2):526-31. PubMed ID: 21889144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Not all statins interfere with clopidogrel during antiplatelet therapy.
    Mach F; Senouf D; Fontana P; Boehlen F; Reber G; Daali Y; de Moerloose P; Sigwart U
    Eur J Clin Invest; 2005 Aug; 35(8):476-81. PubMed ID: 16101667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the factors modulating the effect of statins on malignant cell proliferation.
    Bessler H; Salman H; Bergman M; Djaldetti M
    Cancer Invest; 2007 Aug; 25(5):279-84. PubMed ID: 17661201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
    McKenney JM; Jones PH; Adamczyk MA; Cain VA; Bryzinski BS; Blasetto JW;
    Curr Med Res Opin; 2003; 19(8):689-98. PubMed ID: 14687438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin therapy attenuates growth and malignant potential of human esophageal adenocarcinoma cells.
    Sadaria MR; Reppert AE; Yu JA; Meng X; Fullerton DA; Reece TB; Weyant MJ
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1152-60. PubMed ID: 22014341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental evaluation of analgesic and anti-inflammatory activity of simvastatin and atorvastatin.
    Jaiswal SR; Sontakke SD
    Indian J Pharmacol; 2012; 44(4):475-9. PubMed ID: 23087508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome.
    Deedwania PC; Hunninghake DB; Bays HE; Jones PH; Cain VA; Blasetto JW;
    Am J Cardiol; 2005 Feb; 95(3):360-6. PubMed ID: 15670545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells.
    Ishikawa M; Okajima F; Inoue N; Motomura K; Kato T; Takahashi A; Oikawa S; Yamada N; Shimano H
    J Atheroscler Thromb; 2006 Dec; 13(6):329-35. PubMed ID: 17192698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atorvastatin and simvastatin decrease the uptake of acetylated low-density lipoprotein by human monocytes.
    Tavridou A; Manolopoulos VG
    Pharmacology; 2005 Feb; 73(2):102-5. PubMed ID: 15499225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
    Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
    Turner NA; Midgley L; O'Regan DJ; Porter KE
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells.
    Bessler H; Salman H; Bergman M; Straussberg R; Djaldetti M
    Clin Immunol; 2005 Oct; 117(1):73-7. PubMed ID: 16051523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relaxant effects of pravastatin, atorvastatin and cerivastatin on isolated rat aortic rings.
    Sönmez Uydeş-Doğan B; Topal G; Takir S; Ilkay Alp F; Kaleli D; Ozdemir O
    Life Sci; 2005 Feb; 76(15):1771-86. PubMed ID: 15698855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes.
    Ramachandran S; Saraf S; Shetty C; Capps N; Bailey C
    Ann Clin Biochem; 2011 Jan; 48(Pt 1):75-8. PubMed ID: 21115572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
    Nagaoka T; Hein TW; Yoshida A; Kuo L
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
    Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.